Rongan Zhang

Bristol-Myers Squibb (United States) — United States

Medicine · Health Sciences

14h-index764citations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nitric Oxide and Endothelin Effects(8), Peroxisome Proliferator-Activated Receptors(5), Receptor Mechanisms and Signaling(3), Organic and Inorganic Chemical Reactions(3), Cardiovascular, Neuropeptides, and Oxidative Stress Research(3)

Publications26 total

Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure–Function Post Myocardial Infarction
ACS Pharmacology & Translational Science·2022· 20 citedOpen Access
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
JACC Basic to Translational Science·2021· 54 citedOpen Access
Linking (Pyr)1apelin-13 pharmacokinetics to efficacy: Stabilization and measurement of a high clearance peptide in rodents
Analytical Biochemistry·2018· 14 cited
Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils
Cell Metabolism·2016· 155 citedOpen Access
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective Agonist
ACS Medicinal Chemistry Letters·2016· 6 citedOpen Access
P2Y6 Receptor Potentiates Pro-Inflammatory Responses in Macrophages and Exhibits Differential Roles in Atherosclerotic Lesion Development
PLoS ONE·2014· 89 citedOpen Access
Abstract 13186: Factor XII Deletion Induces Diverse Phenotypes in Preclinical Inflammation Models
Circulation·2013
11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE−/− Mice
PLoS ONE·2013· 31 citedOpen Access
Application of the technology of conversion frequency to polyester production line of Shengyuan in Zhejiang
2011
Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)
Journal of Medicinal Chemistry·2010· 40 citedOpen Access
Synthesis and structure–activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARα selective activators- PPARα and PPARγ selectivity modulation
Bioorganic & Medicinal Chemistry Letters·2010· 10 citedOpen Access
Application of AC-DC-AC Inverter Technology in Secondary Driving of Universal Mill Production Line in Rail and Beam Plant
Advanced materials research·2009
Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist
Journal of Pharmacology and Experimental Therapeutics·2008· 35 citedOpen Access
(3<i>R,</i>5<i>S,E</i>)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1<i>H</i>-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic Acid (BMS-644950): A Rationally Designed Orally Efficacious 3-Hydroxy-3-methylglutaryl Coenzyme-A Reductase Inhibitor with Reduced Myotoxicity Potential
Journal of Medicinal Chemistry·2008· 36 citedOpen Access
The Guinea Pig as a Preclinical Model for Demonstrating the Efficacy and Safety of Statins
Journal of Pharmacology and Experimental Therapeutics·2007· 32 cited
Researching and developing for agricultural fertilizing expert system PDA based on Palm OS
2004
Substituted Pyrazolopyridopyridazines as Orally Bioavailable Potent and Selective PDE5 Inhibitors:  Potential Agents for Treatment of Erectile Dysfunction
Journal of Medicinal Chemistry·2003· 36 citedOpen Access
Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of <i>N</i>-[[2‘-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1‘-biphenyl]- 2-yl]methyl]-<i>N</i>,3,3-trimethylbutanamide (BMS-207940), A Highly Potent and Orally Active ET<sub>A</sub> Selective Antagonist
Journal of Medicinal Chemistry·2002· 62 citedOpen Access
ChemInform Abstract: Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3. Structure—Activity Relationship of 4′‐Heterocyclic Biphenylsulfonamides.
ChemInform·2002
Biphenylsulfonamide Endothelin Receptor Antagonists. Part 3: Structure–Activity Relationship of 4′-Heterocyclic Biphenylsulfonamides
Bioorganic & Medicinal Chemistry Letters·2002· 9 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Debra Search(10), Suzanne Moreland(9), Carol S. Ryan(7), Philip D. Stein(7), Eddie C.‐K. Liu(6), Maria L. Webb(6), Joel C. Barrish(6), Hossain Monshizadegan(6), Denise Grimm(5), Natesan Murugesan(5), Zhengxiang Gu(5), Steven H. Spergel(5), Eileen Bird(5), Thomas Harrity(5), Michael A. Blanar(5), John A. Lupisella(4), Gayani Fernando(4), Ricardo Alexandrino Garcia(4), Sharon N. Bisaha(4), Lawrence J. Kennedy(4)